Inogen Inc (INGN)
9.21
-0.25
(-2.64%)
USD |
NASDAQ |
Nov 21, 16:00
9.22
+0.01
(+0.11%)
After-Hours: 20:00
Inogen Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.0005 |
| June 30, 2016 | 0.0011 |
| March 31, 2016 | 0.0017 |
| December 31, 2015 | 0.0024 |
| September 30, 2015 | 0.003 |
| June 30, 2015 | 0.0036 |
| March 31, 2015 | 0.0044 |
| December 31, 2014 | 0.0052 |
| September 30, 2014 | 0.0058 |
| June 30, 2014 | 0.121 |
| March 31, 2014 | 0.0852 |
| December 31, 2013 | 0.1892 |
| September 30, 2013 | 0.3517 |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 0.3127 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| ResMed Inc | 0.1304 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 306.17M |
| Total Liabilities (Quarterly) | 120.77M |
| Shareholders Equity (Quarterly) | 185.40M |
| Current Ratio | 2.660 |